FBR


FBR Optimistic on Novavax, Inc. (NVAX) Following Management Meeting

FBR analyst Vernon Bernardino met with Novavax, Inc. (NASDAQ:NVAX) management last week to discuss fundamentals and future 2017 clinical development.

FBR Weighs in on Volatile Stocks: Kite Pharma Inc (KITE) and Agile Therapeutics Inc (AGRX)

The biotech-verse was buzzing this week after Kite Pharma Inc (NASDAQ:KITE) submitted an IND application for its pipeline cancer drug that sent shares rising. …

FBR Chimes in on Ballard Power Systems Inc. (USA) (BLDP) Following Joint Venture Agreement with Guangdong Synergy Hydrogen

On December 22nd, Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) offered a progress update on its partnership with local Chinese partner, Guangdong Synergy Hydrogen, …

FBR Offers Commentary on Aurinia Pharmaceuticals Inc (AUPH) Following Receipt of FDA Meeting Minutes

FBR analyst Vernon Bernardino came out with some commentary on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), after the drug maker announced it received meeting minutes for …

FBR Analyst Makes Bearish Case for Chesapeake Energy Corporation (CHK); Here’s Why

Chesapeake Energy Corporation (NYSE:CHK) announced yesterday that it has signed an agreement to sell a portion of its acreage and producing properties in its …

FBR Analyst Adjusts Price Target for Galena Biopharma Inc (GALE) Post Reverse Stock Split

In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Galena Biopharma Inc (NASDAQ:GALE), while adjusting …

FBR Lifts Price Target on Gap Inc (GPS), But Remains Sidelined

Shares of Gap Inc (NYSE:GPS) lost over 10% of their value today after the fashion giant warned investors that store traffic will continue to …

FBR Weighs in on Keryx Biopharmaceuticals (KERX) as FDA Approves Second CMO for Auryxia

FBR Capital analyst Christopher James weighed in with a few insights on Keryx Biopharmaceuticals (NASDAQ:KERX), after the drug maker announced that the FDA granted approval for …

FBR Chimes in on Novavax, Inc. (NVAX) Following Analyst Day

In a research report released Friday, FBR Capital analyst Vernon Bernardino reiterated an Outperform rating on shares of Novavax, Inc. (NASDAQ:NVAX), with a price …

FBR Analyst Comments on Aurinia Pharmaceuticals Inc (AUPH) Following Phase 3 Trial Plans in Lupus Nephritis

In a research report issued Thursday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) with a price …